Taurine could improve insulin resistance by activating the PI3K/AKT/GLUT4 pathway in HFD/STZ-induced T2DM rats and PA-induced IR-HepG2 and the regulatory effects of taurine on the insulin signaling pathway in the liver, the target organ of insulin. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.